Angiotech Vascular Wrap
This article was originally published in The Gray Sheet
Executive Summary
European trial begins study of 60 patients implanted with paclitaxel-eluting wrap for surgical bypass of femoral-popliteal arterial disease. The device is designed to prevent restenosis at the bypass graft anastamosis site from the outside of the vessel in a process similar to the anti-restenotic action of drug-eluting stents. Angiotech is targeting a 2005 U.S. approval of the Vascular Wrap, which will be marketed by C.R. Bard (1"The Gray Sheet, Jan 13, 2003, p. 29)...